Back to Search Start Over

Center-level variation in hospitalization costs of pancreaticoduodenectomy for pancreatic cancer.

Authors :
Le, Nguyen K.
Chervu, Nikhil L.
Ng, Ayesha
Gao, Zihan
Cho, Nam Yong
Charland, Nicole
Nesbit, Shannon M.
Benharash, Peyman
Donahue, Timothy R.
Source :
Surgery; Sep2024, Vol. 176 Issue 3, p866-872, 7p
Publication Year :
2024

Abstract

Pancreaticoduodenectomy is a highly morbid operation with significant resource utilization. Using a national cohort, we examined the interhospital variation in pancreaticoduodenectomy hospitalization cost in the United States. Adults undergoing elective pancreaticoduodenectomy in the setting of pancreatic cancer were tabulated from the 2016–2020 Nationwide Readmissions Database. A 2-level mixed-effects model was developed to evaluate the interhospital variation in pancreaticoduodenectomy hospitalization costs. Institutions within the top decile of risk-adjusted expenditures were defined as high-cost hospitals. Multivariable regression models were fitted to examine the association between high-cost hospital status and outcomes of interest. To account for the effects of complications on expenditures, a subgroup analysis comprising of patients with no adverse events was conducted. The study included an estimated 24,779 patients with a median hospitalization cost of $38,800. After mixed-effects modeling, 40.9% of the cost variation was attributable to hospital, rather than patient, factors. Multivariable regression models revealed an association between high-cost hospital status and greater odds of complications and longer length of stay. Among patients without an adverse event, interhospital cost variation remained significant at 61.0%, and treatment at high-cost hospitals was similarly linked to longer length of stay. Our study identified significant interhospital variation in pancreaticoduodenectomy hospitalization costs in the United States. Although high-cost hospital status was associated with increased odds of complications, variation remained significant even among patients without an adverse event. These results suggest the important role of hospital practices as contributors to expenditures. Further efforts to identify drivers of costs and standardize pancreatic surgical care are warranted. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00396060
Volume :
176
Issue :
3
Database :
Supplemental Index
Journal :
Surgery
Publication Type :
Academic Journal
Accession number :
179060387
Full Text :
https://doi.org/10.1016/j.surg.2024.05.038